Major histocompatibility complex class II expression and parathyroid autoantibodies in primary hyperparathyroidism

Area of Science:

• Immunology
• Endocrinology
• Pathology

Background:

• Autoimmune diseases feature major histocompatibility complex (MHC) class II antigen expression and autoantibodies.
• Viral infections can alter MHC class II expression, potentially contributing to autoimmune reactions.
• The exact cause of primary hyperparathyroidism remains unclear.

Purpose of the Study:

• To investigate potential autoimmune involvement in primary hyperparathyroidism.
• To examine the expression of MHC class II antigens in parathyroid tissues.
• To detect circulating autoantibodies against parathyroid cells in patients.

Main Methods:

• Human parathyroid glands (normal, adenomatous, hyperplastic) were stained for MHC class II antigens using immunohistochemistry.
• Parathyroid adenoma tissue xenografted into nude mice was tested with patient and control sera.
• Rat parathyroid, thyroid, and pancreatic tissues were used as controls.

Main Results:

• MHC class II expression was detected on parathyroid parenchymal cells in a significant portion of patients with primary hyperparathyroidism (adenomatous and hyperplastic glands).
• This reactivity was absent in normal glands and in glands from patients with uremia-related hyperparathyroidism.
• Autoantibodies against parathyroid tissue were found in 27 of 38 patients with primary hyperparathyroidism, but not in controls or on other tissues.

Conclusions:

• The co-occurrence of induced MHC class II antigen expression and circulating autoantibodies in primary hyperparathyroidism suggests a previously unrecognized immune system involvement.
• These findings open new possibilities for understanding the pathogenesis of primary hyperparathyroidism.
• Further research into the immunologic aspects of this endocrine disorder is warranted.